Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_assertion type Assertion NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_head.
- NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_assertion description "[Consistent with these findings in mice, more frequent MYC rearrangements, elevated levels of MYC mRNA, and MYC target genes distinguish human patients with multiple myeloma from individuals with monoclonal gammopathy, implicating a causal role for MYC in the progression of monoclonal gammopathy to multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_provenance.
- NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_assertion evidence source_evidence_literature NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_provenance.
- NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_assertion SIO_000772 18242516 NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_provenance.
- NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_assertion wasDerivedFrom befree-2016 NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_provenance.
- NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_assertion wasGeneratedBy ECO_0000203 NP653162.RAFXcKa5byNDE4Pdz9P00QVOURqVh0ecfqNlpw-JvCwi4130_provenance.